在中国消除乙型肝炎的流行病学,成就和挑战
You Deng1, Tongtong Meng1, Hong You1
1Liver Research Center; The National Clinical Research Center for Digestive Diseases; State Key Laboratory of Digestive Health, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Journal of clinical and translational hepatology
|September 12, 2025
概括
中国通过疫苗接种显著降低了乙型肝炎病毒 (HBV) 感染率,但仍有数百万人患有慢性HBV. 更新的指南旨在改善HBV消除的诊断和治疗覆盖率.
科学领域:
- 公共卫生 公共卫生
- 病毒学 病毒学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 在过去的30年里,中国在乙型肝炎病毒 (HBV) 感染率上取得了实质性的降低.
- 全球HBV疫苗接种一直是基石,防止了数百万的感染和死亡.
- 尽管取得了进展,但中国仍有7500万人患有慢性HBV,诊断和治疗方面存在重大差距.
研究的目的:
- 审查中国在控制慢性乙型肝炎病毒 (HBV) 感染方面的进展.
- 确定HBV诊断和治疗覆盖面的当前挑战.
- 突出实现HBV消除目标的战略方法.
主要方法:
- 对1992年至2020年国家HBV流行数据的分析.
- 对HBV诊断和治疗的最新临床指南的审查.
- 对制药创新和公共卫生干预措施的评估.
主要成果:
- 乙型肝炎表面抗原的患病率从9.72% (1992) 降至5.86% (2020),五岁以下儿童的患病率急剧下降.
- 自1992年以来,通过疫苗接种避免了超过4000万例感染和700万例死亡.
- 仍然存在显著的差距:59.78%的人不知道感染,只有17.33%的符合条件的患者接受治疗.
结论:
- 中国更新的指导方针和对诊断/治疗覆盖率的关注对于实现世卫组织消除目标至关重要.
- 积极参与开发新型疗法的目标是功能性HBV治疗.
- 中国的综合战略为全球消除HBV的努力提供了宝贵的见解.
相关概念视频
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...


